Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03816709 · ClinicalTrials.gov registry record · NA
Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound
A NA study, sponsored by North Dakota State University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03816709: Completed NA study, sponsored by North Dakota State University.
NCT03816709 is a NA study that has completed, run by North Dakota State University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03816709, a NA study, has completed, sponsored by North Dakota State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the rate of tissue temperature increase in the triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment time. Thermocouples will be inserted at 1.0, 1.75, and 2.5 cm depths to determine the heating rates. Most modality textbook recommendations for therapeutic ultrasound are based on studies performed with the Omnisound ultrasound machine. Previous research has shown variations in power output across manufacturers, producing differences in tissue temperature increases. No information has been published regarding the heating rates of the Chattanooga Intelect Legend XT machine for ultrasound treatments. By determining the heating rates for this machine, clinicians will be better able to utilize the Chattanooga Intelect Legend XT to help reach therapeutic goals.
Primary Outcome
A thermocouple was inserted at the 1 cm depth to determine the tissue temperatures.
Interventions
- DEVICE Therapeutic Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-02-05 |
| Est. Completion | 2020-05-11 |
| Phase | NA |
What the finished NCT03816709 record still lists
NCT03816709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Therapeutic Ultrasound is the first listed.
NCT03816709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03816709 about?
NCT03816709 is a clinical study titled "Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound". The purpose of this study is to determine the rate of tissue temperature increase in the triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment time. Thermocouples will be...
What is the current status of trial NCT03816709?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-02-05. Estimated completion is 2020-05-11.
What interventions are being tested in trial NCT03816709?
The interventions under investigation include: Therapeutic Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03816709?
This trial is sponsored by North Dakota State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03816709's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI